| 1. | neil2484 | |
| 2. | davichalfan9 | |
| 3. | gonefishinnow | |
| 4. | lisamaree915 | |
| 5. | steh3587 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | moomoo7susan 02/21/2018 Sanford C. Bernstein reiterates Outperform rating; PT lowered to $60 from $71 |
| 2. | davichalfan9 02/20/2018 Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress |
| 3. | neil2484 01/26/2018 Licensing and Supply Agreement |
| 4. | steh3587 05/10/2018 Barclays raises price target to $85 from $64 |
| 5. | neil2484 01/03/2018 News out! |
| 6. | gonefishinnow 02/21/2018 Stifel Nicolaus cuts PT to $64 from $73 |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Spark Therapeutics, Inc.
- ONCE
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.